Humanized monoclonal antibodies against human interleukin-4
US5863537A · kind A · utility
21Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 1994 |
| Grant date | Jan 26, 1999 |
| Priority date | — |
| Expiry date | Aug 16, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies are provided which are specific for human interleukin-4. Also provided are complementary DNAs which encode the heavy and light chain variable regions of such monoclonal antibodies and complementarity determining regions from such DNAs; and kits and methods for detecting, measuring and immunopurifying human interleukin-4, and for blocking the biological activity of human interleukin-4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.